NVS NOVARTIS AG
NYSEHealth carePharmaceutical PreparationsBasel, SwitzerlandFY ends December 31
This company has no annual 10-K financial data in SEC EDGAR's XBRL facts (for example, foreign issuers that file Form 20-F, funds, or very small filers). Its filings are listed below.
Overview
NOVARTIS AG (NVS) is listed on NYSE; the SEC classifies it under "Pharmaceutical Preparations".
- Fiscal years shown
- —
- Latest 10-K
- —
- Latest filing
- 6-KOct 27, 2026
Filing timeline
- 6-KReport of foreign issuer· Sep 30, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Sep 8, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Sep 4, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Sep 1, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Jun 30, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Jun 11, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Mar 31, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Mar 18, 2026(SEC EDGAR)
- 6-KReport of foreign issuer· Dec 31, 2025(SEC EDGAR)
- 6-KReport of foreign issuer· Dec 31, 2025(SEC EDGAR)
Peers (same SIC code)
| Ticker | Revenue (FY) | YoY | Net margin | ROE | F-Score | 5y revenue |
|---|---|---|---|---|---|---|
| JNJJOHNSON & JOHNSON | $94.2B | — | 28.5% | — | — | — |
| LLYELI LILLY & Co | $65.2B | — | 31.7% | — | — | — |
| MRKMerck & Co., Inc. | $65B | — | 28.1% | — | — | — |
| ABBVAbbVie Inc. | $61.2B | — | 6.9% | — | — | — |
| NVSNOVARTIS AG (This company) | — | — | — | — | — | — |
| AZNASTRAZENECA PLC | — | — | — | — | — | — |
| Peer median | $65.1B | — | 28.3% | — | — | — |
Companies with the same 4-digit SIC code, ordered by latest revenue. The median excludes this company. — = not reported or not computable.
Frequently asked questions
What does NOVARTIS AG do?
The SEC classifies NOVARTIS AG under Standard Industrial Classification (SIC) code 2834, "Pharmaceutical Preparations". It is headquartered in Basel, Switzerland. It is incorporated in Switzerland.
Where is NOVARTIS AG listed?
According to the SEC, NOVARTIS AG's ticker NVS is listed on NYSE. The SEC also lists the ticker NVSEF for the company.
When does NOVARTIS AG's fiscal year end?
According to the SEC, NOVARTIS AG's fiscal year ends on December 31.
Source: SEC EDGAR · Last updated:
Ver en españolNot investment advice: This page shows financial data that companies reported to the US Securities and Exchange Commission, for information only. It is not investment advice or a recommendation to buy or sell any security, and it shows no stock prices. Data may be incomplete, restated or out of date — check the original filings on SEC EDGAR before making decisions.